The Commission on Cancer requires that patients be followed:

• A. For a minimum of five years
• B. For the lifetime of the patient
• C. Until the completion of treatment
• D. Until the patient reaches age 70

Answer: (B)

The Commission on Cancer mandates that patients be followed for the lifetime of the patient. This requirement is established to ensure comprehensive care and monitoring of cancer cases. Lifetime follow-up allows for early detection of recurrences, assessment of long-term effects from treatment, management of any subsequent malignancies, and ensures that patients receive appropriate supportive care as needed.

Following patients throughout their lives also supports data collection for research purposes and enhances understanding of cancer trends, treatment outcomes, and survivorship issues. This continuous follow-up approach aligns with the broader goals of improving patient care and outcomes in oncology, reflecting the complexity and long-term nature of cancer treatment and survivorship.